FCA
MRNA icon

Fortis Capital Advisors’s Moderna MRNA Stock Holding History

Fortis Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Sell
29,428
-4,614
-14% -$239K 0.23% 75
2026
Q1 		$1.73M Buy
34,042
+25,827
+314% +$1.2M 0.23% 72
2025
Q4 		$242K Buy
8,215
+7
+0.1% +$190 0.04% 269
2025
Q3 		$212K Hold
8,208
– – 0.03% 261
2025
Q2 		$226K Buy
8,208
+15
+0.2% +$395 0.04% 222
2025
Q1 		$232K Buy
+8,193
New +$291K 0.05% 230

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fortis Capital Advisors's MRNA Position: Q2 2026 in Review

Fortis Capital Advisors reduced its Moderna (MRNA) stake by 14% in Q2 2026, selling an estimated $239K and leaving 29,428 shares worth $2.06M. The position accounts for 0.23% of the portfolio, ranked #75.

Fortis Capital Advisors first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fortis Capital Advisors held 29,428 shares of Moderna worth $2.06M as of Q2 2026.
  • Fortis Capital Advisors sold 4,614 Moderna shares in Q2 2026, an estimated $239K.
  • Moderna made up 0.23% of Fortis Capital Advisors's portfolio in Q2 2026, its #75 holding.
  • Fortis Capital Advisors first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.